HCV: Case-Based Video Vignettes
  1. Course List
Featured Speaker(s)
faculty image
Steven L. Flamm, MD
  • Professor of Medicine and Surgery
  • Division of Gastroenterology and Hepatology
  • Northwestern University
  • Feinberg School of Medicine
  • Chicago, Illinois
  • faculty image
    Zobair M. Younossi, MD, MPH, FACP. FACG, AGAF
  • Professor of Medicine
  • Virginia Commonwealth University-Inova Campus
  • Executive Director of Research
  • Inova Health System
  • Executive Director, Center for Liver Diseases
  • Inova Fairfax Hospital
  • Falls Church, Virginia
  • This Point-of-Care clinical companion focuses on the new treatment paradigm for hepatitis C virus (HCV) infection - €”direct-acting antiviral (DAA) agents - €”through a collection of case-based video vignettes.
  • Assess patients who may benefit from direct-acting antiviral (DAA) therapy and initiate treatment, where appropriate, to improve response rate.
  • Contrast currently approved DAA anti-HCV therapies and formulate potential treatment strategies in chronically HCV-infected patients (including treatment-naive patients, nonresponders, partial responders, and relapsers) by analyzing efficacy, safety, and side effect data, and duration of treatment.
  • Target Audience

    These CME/CE activities have been designed for gastroenterologists, hepatologists, nurses, nurse practitioners, physician assistants, and pharmacists involved in the care of patients with HCV or those at risk of acquiring the infection.


    Activity Goal

    The goal of these CME/CE activities is to provide up-to-date information on key issues and management strategies for hepatitis C in order to improve patient outcomes.